Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Ion AmpliSeq Community Panels from Life Technologies

Ion AmpliSeq Community Panels from Life Technologies

Selective blocking of HDAC11 inhibitor would act exclusively on tumor cells

Selective blocking of HDAC11 inhibitor would act exclusively on tumor cells

PsiOxus receives UK government grant to initiate ColoAd1 Phase I/II trial for ovarian cancer

PsiOxus receives UK government grant to initiate ColoAd1 Phase I/II trial for ovarian cancer

Sequana Medical announces CE mark approval of alfapump for patients with malignant ascites

Sequana Medical announces CE mark approval of alfapump for patients with malignant ascites

Azaya Therapeutics commences ATI-0918 bioequivalence study in ovarian cancer

Azaya Therapeutics commences ATI-0918 bioequivalence study in ovarian cancer

Study to examine possible link between mitochondrial DNA and ovarian cancer

Study to examine possible link between mitochondrial DNA and ovarian cancer

AAPS recognizes top scientists in pharmaceutical sciences

AAPS recognizes top scientists in pharmaceutical sciences

New research lists cell stiffness as possible biomarker for metastatic ovarian cancer

New research lists cell stiffness as possible biomarker for metastatic ovarian cancer

Aspirin associated with reduced risk of serious ovarian cancer

Aspirin associated with reduced risk of serious ovarian cancer

New type of drug for drug-resistant cancer

New type of drug for drug-resistant cancer

Five prominent surgeons receive Honorary Fellowship from ACS

Five prominent surgeons receive Honorary Fellowship from ACS

Lilly announces new data from two Phase II ramucirumab trials on NSCLC

Lilly announces new data from two Phase II ramucirumab trials on NSCLC

UNMCC to investigate R-ketorolac use against ovarian cancer cells

UNMCC to investigate R-ketorolac use against ovarian cancer cells

MiR-214 plays a critical role in regulating ovarian cancer stem cell properties

MiR-214 plays a critical role in regulating ovarian cancer stem cell properties

Enrollment complete in Boehringer Ingelheim’s nintedanib phase III studies for IPF

Enrollment complete in Boehringer Ingelheim’s nintedanib phase III studies for IPF

Young women with BRCA mutations feel differently about options for relationships, careers

Young women with BRCA mutations feel differently about options for relationships, careers

Researchers discover genetics secrets of ovarian cancer tumors

Researchers discover genetics secrets of ovarian cancer tumors

Molecular similarity between one sub-type of breast cancer and ovarian cancer

Molecular similarity between one sub-type of breast cancer and ovarian cancer

Simple survey can effectively identify women with ovarian cancer symptoms

Simple survey can effectively identify women with ovarian cancer symptoms

Most basal-like breast and ovarian tumors have similar genetic origins

Most basal-like breast and ovarian tumors have similar genetic origins

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.